Login / Signup
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients.
Kai Ding
Zhaoyun Liu
Yue Ren
Hui Liu
Wenhui Lei
Published in:
Annals of hematology (2023)
Keyphrases
</>
end stage renal disease
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
combination therapy
drug induced